Why Pharma Companies Need Strategic CDMO Partnerships?
(YorkPedia Editorial):- San Diego, California Sep 9, 2026 (Issuewire.com) – Pharmaceutical companies are rethinking how they choose development and manufacturing partners. As pipelines expand into peptides, oligonucleotides, targeted protein degraders, and other complex modalities, the old model of hiring a contractor to execute a defined scope of work is giving way to something closer to a strategic partnership. Programs increasingly need partners who can solve unfamiliar technical problems, operate under consistent quality standards across regions, and move quickly without cutting corners. Molecular Complexity Is Redefining What Partners Are Asked to Do As drug…
Read More